THE ROLE OF BIOLOGIC AGENTS IN THE MANAGEMENT OF RHEUMATOLOGICAL DISEASES
Khaled Abulhassan Ibrahim Hassan;
Abstract
Biologic drugs are now available for the treatment of some rheumatic diseases. Etanercept (Enbrel) is a soluble receptor fusion protein that binds to soluble TNF neutralizing its biologic activities. Infliximab (Remicade) is a chimeric monoclonal antibody
Other data
| Title | THE ROLE OF BIOLOGIC AGENTS IN THE MANAGEMENT OF RHEUMATOLOGICAL DISEASES | Other Titles | دور الأدوية البيولوجية فى معالجة الأمراض الروماتيزمية | Authors | Khaled Abulhassan Ibrahim Hassan | Keywords | THE ROLE OF BIOLOGIC AGENTS IN THE MANAGEMENT OF RHEUMATOLOGICAL DISEASES | Issue Date | 2012 | Description | Biologic drugs are now available for the treatment of some rheumatic diseases. Etanercept (Enbrel) is a soluble receptor fusion protein that binds to soluble TNF neutralizing its biologic activities. Infliximab (Remicade) is a chimeric monoclonal antibody |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 111678r7654.pdf | 496.84 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.